Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2017

Nov 16, 2017

34129_dirs_2017-11-15_a77d5509-ff9b-420b-b64c-0be13278a3aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-11-13

Reporting Person: SIEGEL JAY PHILIP (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-13 Stock Option (right to buy) $17.85 A 20000 Acquired 2017-11-13 Common Stock (20000.0) Direct

Footnotes

F1: (1) The option will vest 1/12th of the shares monthly, beginning on the first monthly anniversary of the grant date and will become fully exercisable 1 year from the date of grant (11/13/18).